HOMOGENEOUS TIME-RESOLVED FLUORESCENCE DNA

Award Information
Agency:
Department of Health and Human Services
Branch
n/a
Amount:
$42,959.00
Award Year:
1989
Program:
SBIR
Phase:
Phase I
Contract:
n/a
Agency Tracking Number:
11255
Solicitation Year:
n/a
Solicitation Topic Code:
n/a
Solicitation Number:
n/a
Small Business Information
Enzo Biochem Inc
325 Hudson St, New York, NY, 10013
Hubzone Owned:
N
Socially and Economically Disadvantaged:
N
Woman Owned:
N
Duns:
n/a
Principal Investigator:
() -
Business Contact:
() -
Research Institution:
n/a
Abstract
THE AIM OF THIS STUDY IS TO DEVELOP A NONRADIOACTIVE, HOMOGENEOUS HYBRIDIZATION ASSAY FOR IDENTIFYING BACTERIAL AND VIRAL PATHOGENS IN CLINICAL SPECIMENS. HYBRIDIZATION WILL BE MONITORED USING A NOVEL TIME-RESOLVED FLUORESCENCE (TRF) INSTRUMENT TO DETECT FLUORESCENCE RESULTING FROM ENERGY TRANSFER BETWEEN DYES INTERCALATED INTO THE HYBRIDS (ENERGY DONORS) AND EU(3+) ATTACHED TO OLIGONUCLEOTIDE PROBES BY CHELATION (ENERGY ACCEPTORS). IN PHASE I, A MODEL SYSTEM CONSISTING OF POLY-DA TARGET SEQUENCES AND OLIGO-DT PROBES LABELED WITH EU(3+) WAS USED TO DEMONSTRATE THE FEASIBILITY OF THIS APPROACH. 9-AMINOACRIDINE WAS USED AS THE DONOR MOLECULE. OPTIMAL HYBRIDIZATION AND DETECTION CONDITIONS WERE DETERMINED, AND PRELIMINARY SENSITIVITY DETERMINATIONS WERE MADE. MORE DETAILED ANALYSES OF LABELING, HYBRIDIZATION, AND DETECTION PARAMETERS WILL BE PERFORMED IN PHASE II, WHERE THE ASSAY WILL BE APPLIED TO THE DETECTION OF BACTERIAL PATHOGENS IN SPECIMENS. THIS TRF-DNA ASSAY WILL BE FASTER, SIMPLER, AND AT LEAST AS SENSITIVE AS EXISTING RADIOACTIVE HYBRIDIZATION-DETECTION ASSAYS. IT REPRESENTS A SIGNIFICANT ADVANCE OVER THESE TECHNOLOGIES AND PROMISE TO HAVE CONSIDERABLE IMPACT ON THE DEVELOPMENT OF COMMERCIALLY RELEVANT DNA-BASED DIAGNOSTICS.

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government